284 related articles for article (PubMed ID: 15264968)
1. The relationship between antipsychotic treatment and quality of life for patients with dementia living in residential and nursing home care facilities.
Ballard CG; Margallo-Lana ML
J Clin Psychiatry; 2004; 65 Suppl 11():23-8. PubMed ID: 15264968
[TBL] [Abstract][Full Text] [Related]
2. Behavioral and psychological symptoms in dementia: the role of atypical antipsychotics.
Lawlor BA
J Clin Psychiatry; 2004; 65 Suppl 11():5-10. PubMed ID: 15264965
[TBL] [Abstract][Full Text] [Related]
3. Management of agitation, aggression, and psychosis associated with dementia: a pooled analysis including three randomized, placebo-controlled double-blind trials in nursing home residents treated with risperidone.
De Deyn PP; Katz IR; Brodaty H; Lyons B; Greenspan A; Burns A
Clin Neurol Neurosurg; 2005 Oct; 107(6):497-508. PubMed ID: 15922506
[TBL] [Abstract][Full Text] [Related]
4. Mortality in elderly dementia patients treated with risperidone.
Haupt M; Cruz-Jentoft A; Jeste D
J Clin Psychopharmacol; 2006 Dec; 26(6):566-70. PubMed ID: 17110812
[TBL] [Abstract][Full Text] [Related]
5. The efficacy and safety of risperidone in the treatment of psychosis of Alzheimer's disease and mixed dementia: a meta-analysis of 4 placebo-controlled clinical trials.
Katz I; de Deyn PP; Mintzer J; Greenspan A; Zhu Y; Brodaty H
Int J Geriatr Psychiatry; 2007 May; 22(5):475-84. PubMed ID: 17471598
[TBL] [Abstract][Full Text] [Related]
6. Advantages and disadvantages of combination treatment with antipsychotics ECNP Consensus Meeting, March 2008, Nice.
Goodwin G; Fleischhacker W; Arango C; Baumann P; Davidson M; de Hert M; Falkai P; Kapur S; Leucht S; Licht R; Naber D; O'Keane V; Papakostas G; Vieta E; Zohar J
Eur Neuropsychopharmacol; 2009 Jul; 19(7):520-32. PubMed ID: 19411165
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of atypical antipsychotics in elderly patients with dementia.
Tariot PN; Profenno LA; Ismail MS
J Clin Psychiatry; 2004; 65 Suppl 11():11-5. PubMed ID: 15264966
[TBL] [Abstract][Full Text] [Related]
8. Quality of life in the long-term treatment and the role of second-generation antipsychotics.
Mohr P
Neuro Endocrinol Lett; 2007 Feb; 28 Suppl 1():117-33. PubMed ID: 17262004
[TBL] [Abstract][Full Text] [Related]
9. Quetiapine treatment for behavioural and psychological symptoms of dementia in Alzheimer's disease patients: a 6-week, double-blind, placebo-controlled study.
Paleacu D; Barak Y; Mirecky I; Mazeh D
Int J Geriatr Psychiatry; 2008 Apr; 23(4):393-400. PubMed ID: 17879256
[TBL] [Abstract][Full Text] [Related]
10. [Antipsychotics against anxiety in dementia: medical treatment or chemical restraints?].
Ruths S; Straand J
Tidsskr Nor Laegeforen; 2005 Jun; 125(12):1672-5. PubMed ID: 15976839
[TBL] [Abstract][Full Text] [Related]
11. Comparative efficacy of risperidone versus haloperidol on behavioural and psychological symptoms of dementia.
Suh GH; Greenspan AJ; Choi SK
Int J Geriatr Psychiatry; 2007 May; 22(5):494-5. PubMed ID: 17471597
[No Abstract] [Full Text] [Related]
12. Use of quetiapine in elderly patients.
Tariot PN; Ismail MS
J Clin Psychiatry; 2002; 63 Suppl 13():21-6. PubMed ID: 12562143
[TBL] [Abstract][Full Text] [Related]
13. Randomized controlled trial of the effect on Quality of Life of second- vs first-generation antipsychotic drugs in schizophrenia: Cost Utility of the Latest Antipsychotic Drugs in Schizophrenia Study (CUtLASS 1).
Jones PB; Barnes TR; Davies L; Dunn G; Lloyd H; Hayhurst KP; Murray RM; Markwick A; Lewis SW
Arch Gen Psychiatry; 2006 Oct; 63(10):1079-87. PubMed ID: 17015810
[TBL] [Abstract][Full Text] [Related]
14. Atypical antipsychotics for the treatment of dementia-related behaviors: an update.
Daiello LA
Med Health R I; 2007 Jun; 90(6):191-4. PubMed ID: 17633594
[TBL] [Abstract][Full Text] [Related]
15. Psychotropic drug use in older people with mental illness with particular reference to antipsychotics: a systematic study of tolerability and use in different diagnostic groups.
Curran S; Turner D; Musa S; Wattis J
Int J Geriatr Psychiatry; 2005 Sep; 20(9):842-7. PubMed ID: 16116576
[TBL] [Abstract][Full Text] [Related]
16. Effect of acetaminophen on behavior, well-being, and psychotropic medication use in nursing home residents with moderate-to-severe dementia.
Chibnall JT; Tait RC; Harman B; Luebbert RA
J Am Geriatr Soc; 2005 Nov; 53(11):1921-9. PubMed ID: 16274373
[TBL] [Abstract][Full Text] [Related]
17. Neuropsychiatric symptoms and quality of life in patients in the final phase of dementia.
Koopmans RT; van der Molen M; Raats M; Ettema TP
Int J Geriatr Psychiatry; 2009 Jan; 24(1):25-32. PubMed ID: 18512257
[TBL] [Abstract][Full Text] [Related]
18. Risperidone for psychosis of Alzheimer's disease and mixed dementia: results of a double-blind, placebo-controlled trial.
Brodaty H; Ames D; Snowdon J; Woodward M; Kirwan J; Clarnette R; Lee E; Greenspan A
Int J Geriatr Psychiatry; 2005 Dec; 20(12):1153-7. PubMed ID: 16315159
[TBL] [Abstract][Full Text] [Related]
19. The effect of risperidone on nursing burden associated with caring for patients with dementia.
Frank L; Kleinman L; Ciesla G; Rupnow MF; Brodaty H
J Am Geriatr Soc; 2004 Sep; 52(9):1449-55. PubMed ID: 15341545
[TBL] [Abstract][Full Text] [Related]
20. Treatment of behavior disorders in mental retardation: report on transitioning to atypical antipsychotics, with an emphasis on risperidone.
Aman MG; Gharabawi GM;
J Clin Psychiatry; 2004 Sep; 65(9):1197-210. PubMed ID: 15367046
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
